BIOLAN HEALTH is a biotechnology company that develops and manufactures advanced biosensors and in vitro diagnostic systems. It provides fast, accurate point-of-care testing solutions for health and clinical diagnostics.
BIOLAN HEALTH is a biotechnology company that develops, manufactures, and commercializes in vitro diagnostic systems and biosensors for the health industry. The company specializes in creating miniaturized diagnostic tools based on enzymatic biosensor technology and lateral flow immunoassays. These point-of-care (PoC) devices are designed to provide rapid, accurate, and reliable quantitative results using minimal sample volumes, serving sectors including hospitals, clinical analysis laboratories, and biotechnology firms.
By leveraging proprietary biosensor technology, the company addresses specific diagnostic needs, such as its OSAXYL system for the diagnosis of hypolactasia (lactose intolerance) and rapid serological tests for COVID-19 detection. These solutions provide healthcare providers with fast, economical, and precise monitoring capabilities. As part of the BIOLAN group, the company continues to innovate through R&D and strategic collaborations, aiming to enhance clinical outcomes through advanced analytical technology and digital transformation in diagnostics.